| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/20/2006 | CN1882572A Quinazoline derivatives as antitumor agents |
| 12/20/2006 | CN1882570A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882569A 喹唑啉衍生物 Quinazoline derivatives |
| 12/20/2006 | CN1882567A Quinazoline derivatives as tyrosine kinase inhibitors |
| 12/20/2006 | CN1882365A Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 12/20/2006 | CN1882350A Method for controlling angiogenesis in animals |
| 12/20/2006 | CN1882344A Inhibitors of the mutant form of KIT |
| 12/20/2006 | CN1882343A Use of cathepsin k inhibitors for treating of severe bone loss diseases |
| 12/20/2006 | CN1882342A Use of CHK1 inhibitors to control cell proliferation |
| 12/20/2006 | CN1882319A Anti-tumour terpene compounds |
| 12/20/2006 | CN1880455A Human tumor suppressor gene NECL2 and apoptosis of leukemia cells induced by its interactive protein |
| 12/20/2006 | CN1880444A Grifola frondosa strain, culture method and application thereof |
| 12/20/2006 | CN1880336A Cancer-targeted super antigen fusion protein and its production method |
| 12/20/2006 | CN1880332A siRNA double-chain for suppressing bc1-2 gene expression |
| 12/20/2006 | CN1880331A siRNA double-chain for suppressing bc1-2 gene expression |
| 12/20/2006 | CN1880330A siRNA double-chain for suppressing bc1-2 gene expression |
| 12/20/2006 | CN1880317A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/20/2006 | CN1880315A N2-quinoline or isoquinoline substituted purine derivative and its preparation method and uses |
| 12/20/2006 | CN1880313A Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell |
| 12/20/2006 | CN1880309A Novel compound, bacteria strain and method for producing novel compound using the strain |
| 12/20/2006 | CN1879890A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 12/20/2006 | CN1879881A Yeast vaccine production method |
| 12/20/2006 | CN1879874A Glutathion complex pharmaceutical composition |
| 12/20/2006 | CN1879872A Method for researching effective substance of compound of traditional Chinese medicine |
| 12/20/2006 | CN1879850A Capsule with hairy vein agrimony and arenobufagin, its preparation process and quality control method |
| 12/20/2006 | CN1879849A Compound capsule with pseudo-ginseng and Chinese fanpalm seed, its preparation process and quality control method |
| 12/20/2006 | CN1879842A A Chinese medicine for treating cancer |
| 12/20/2006 | CN1879841A A Chinese medicine for treating leukemia |
| 12/20/2006 | CN1879819A Medicinal pill, watered pill, honeyed pill for treating H22 liver cancer and method for preparing same |
| 12/20/2006 | CN1879818A A medicine for treating H22-liver cancer and method for preparing same |
| 12/20/2006 | CN1879775A Chinese medicine for treating soft and hard tumor and method for preparing same |
| 12/20/2006 | CN1879764A Medical use of iris |
| 12/20/2006 | CN1879758A Medicine for treating leukemia and preparation method thereof |
| 12/20/2006 | CN1879755A Chinese medicinal composition for preparing tumor-treating medicine |
| 12/20/2006 | CN1879692A Novel use of camphor tree in toxin expelling, detoxication, cancer prevention, cancer resistance and beauty treatment |
| 12/20/2006 | CN1879687A An anti-tumor pharmaceutical composition and preparation method thereof |
| 12/20/2006 | CN1879672A A medicament containing effective components of glabrous sarcandra herb, its preparation method and application |
| 12/20/2006 | CN1879658A Application of cantharis in medicament preparation |
| 12/20/2006 | CN1879653A Bezoar nano-powder preparation process and pharmaceutical preparation thereof |
| 12/20/2006 | CN1879647A Solid dispersion of protopanaxadiol and preparation method thereof |
| 12/20/2006 | CN1879631A Oral rapid-release cucurbitacine tablet and preparation method thereof |
| 12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/20/2006 | CN1879623A Methods of preventing breast cancer |
| 12/20/2006 | CN1879619A Cancer treatment |
| 12/20/2006 | CN1879616A Application of tectori-genin in preparation of medicine for preventing and treating liver disease and liver cancer |
| 12/20/2006 | CN1879615A Anti-tumor synergistic pharmaceutical composition |
| 12/20/2006 | CN1879613A Medicine containing galangin and preparation method thereof |
| 12/20/2006 | CN1879612A Nano particles of taxane cyclodextrin inclusion compound and preparation method thereof |
| 12/20/2006 | CN1879607A A sodium alginate microsphere vascular embolizing agent containing water soluble drug, its preparation and application |
| 12/20/2006 | CN1291029C Metabolic compound of HLY2 and its preparation |
| 12/20/2006 | CN1290864C Ant CD20 chimeric antibody |
| 12/20/2006 | CN1290862C Spleen polypeptide extract, its preparing process and use |
| 12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor |
| 12/20/2006 | CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 12/20/2006 | CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/20/2006 | CN1290826C Novel substituted propanamide benzoyl urea derivatives, medicinal composition containg same and use thereof |
| 12/20/2006 | CN1290562C Chinese traditional medicine composition for resisting malignant tumor (cancer) |
| 12/20/2006 | CN1290546C Preparation method of medicine for treating malignant lymphoma |
| 12/20/2006 | CN1290538C Chinese medicinal powder for treating stomach tumor |
| 12/20/2006 | CN1290525C A blood-sugar lowering botanical extract and its use |
| 12/20/2006 | CN1290512C Pharmaceutical composition containing ginseng polysacchride and astragalus polysaccharide, its preparation and application |
| 12/20/2006 | CN1290511C Doxorubicin liposome hydrochloride preparation and its preparing method |
| 12/20/2006 | CN1290505C PH sensitive controllable nanometer particle carried with 5-Fu and its preparation method |
| 12/20/2006 | CN1290504C Combination comprising combretastatin and anticancer agents |
| 12/20/2006 | CN1290501C Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | CN1290492C Beta-elemene aerosol and its preparing method |
| 12/20/2006 | CN1290489C Toad extract liposome preparation for injection and its preparing method |
| 12/19/2006 | USRE39436 Interventions to mimic the effects of calorie restriction |
| 12/19/2006 | USRE39433 Therapeutic agents as cytokine antagonists and agonists |
| 12/19/2006 | US7151176 5-[(4-aminopiperidin-1-yl)methyl]-N-[(1R)-1-phenylethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; antiproliferative agents; inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 |
| 12/19/2006 | US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma |
| 12/19/2006 | US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 12/19/2006 | US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 12/19/2006 | US7151109 Psychological disorders; anxiolytic agents; antidepressants |
| 12/19/2006 | US7151108 Anticarcinogenic, antiproliferative, and antitumor agents |
| 12/19/2006 | US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 12/19/2006 | US7151104 Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |
| 12/19/2006 | US7151100 Indole compounds useful for the treatment of cancer |
| 12/19/2006 | US7151092 Cytarabine monophosphate prodrugs |
| 12/19/2006 | US7150983 Modified proteolytic enzyme for treatment of osteoarthritis |
| 12/19/2006 | US7150976 Regulation of human serine-threonine protein kinase |
| 12/19/2006 | US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 12/19/2006 | US7150870 Treatment of tumors with superoxide dismutase for prevention by applying to tumors |
| 12/19/2006 | US7150869 Gene therapy; cytokine complex; anticancer agent |
| 12/19/2006 | US7150867 Radionuclide-coated particulate material |
| 12/19/2006 | CA2194761C Immunomodulatory oligonucleotides |
| 12/19/2006 | CA2168659C Substituted azaindolylidene compounds and process for their preparation |
| 12/19/2006 | CA2158863C Taxanes having a pyridyl substituted side-chain |
| 12/16/2006 | CA2512492A1 Methods and reagents for inhibiting cell proliferation |
| 12/14/2006 | WO2006133417A1 Phenylamino isothiazole carboxamidines as mek inhibitors |
| 12/14/2006 | WO2006133398A2 In vitro activated donor t-cells to promote transplant engraftment |
| 12/14/2006 | WO2006133164A2 Anti-trkb monoclonal antibodies and uses thereof |
| 12/14/2006 | WO2006133147A2 Organic compounds |
| 12/14/2006 | WO2006132930A1 Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 12/14/2006 | WO2006132907A2 Methods of treating, diagnosing or detecting cancer using an ephb3 modulator |
| 12/14/2006 | WO2006132587A1 Tumour marker in brca2 associated breast cancer |
| 12/14/2006 | WO2006132586A1 Use of plant cell membrane for the for the treatment of obesity |